(Q44062360)

29 November 2017

title

Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial (English)

1 reference

29 November 2017

main subject

phase II clinical trial

0 references

head and neck carcinoma

1 reference

Martina Baur

1

1 reference

29 November 2017

Heinz-Roland Kienzer

2

1 reference

29 November 2017

Johannes Schweiger

3

1 reference

29 November 2017

Maria DeSantis

4

1 reference

29 November 2017

Erich Gerber

5

1 reference

29 November 2017

Jörg Pont

6

1 reference

29 November 2017

Marcus Hudec

7

1 reference

29 November 2017

Annemarie Ulrike Schratter-Sehn

8

1 reference

29 November 2017

Wolfram Wicke

9

1 reference

29 November 2017

Christian Dittrich

10

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

94

1 reference

29 November 2017

issue

11

1 reference

29 November 2017

page(s)

2953-2958

1 reference

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

Energy and protein requirements of patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Reticuloendothelial Function in Patients with Alcoholic Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10574

7 January 2021

Identifiers

DOI

10.1002/CNCR.10574

1 reference

29 November 2017

1 reference